skip to main content

Prostate Cancer

Researchers propose new approach to identify genetic mutations in men with prostate cancer

Date Visible: 
Thursday, June 29, 2017 - 11:30

In a new study, researchers used a patient's own cancer history rather than family history to identify genetic mutations that might influence cancer treatment and risk for family members.

How precision medicine is improving prostate cancer detection

Date Visible: 
Tuesday, May 9, 2017 - 10:30
New, statistically derived guidelines are helping urologists across Michigan zero in on which prostate cancer patients to scan for spread of their disease.

A new approach to target an 'undruggable' prostate cancer driver

Date Visible: 
Thursday, March 23, 2017 - 12:00

When small-molecule inhibitors proved elusive, researchers developed a novel strategy: Using large molecule peptides to target a common prostate cancer driver. It may provide a path for developing new therapies against a challenging target.

Michigan Medicine opens first prostate cancer risk clinic in the nation

Date Visible: 
Wednesday, March 1, 2017 - 14:00
It’s well known that women with certain hereditary genetic mutations, particularly BRCA1 and BRCA2, have an increased risk of breast cancer. But in recent years, researchers have discovered a link between some of those same genetic mutations – along with a handful of others – and aggressive prostate cancer.